Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells
John M. Perry, Tao Fang, Anuradha Roy, Tara L. Lin, Xi He, Shiyuan Chen, Xiuling Lü, Jacqelyn Nemechek, Linhao Ruan, Xiazhen Yu, Debra Dukes, Andrea Moran, Jennifer R. Pace, Kealan Schroeder, Meng Zhao, Aparna Venkatraman, Pengxu Qian, Zhenrui Li, Mark Hembree, Ariel Paulson, Zhiquan He, Dong Xu, Thanh-Huyen Tran, Prashant Deshmukh, Chi Nguyen, Rajeswari M. Kasi, Robin Ryan, Melinda Broward, Sheng Ding, Erin Guest, Keith J. August, Alan S. Gamis, Andrew K. Godwin, G. Sitta Sittampalam, Scott J. Weir, Linheng Li
Topics & Concepts
Wnt signaling pathwayCancer researchProtein kinase BStem cellCancer stem cellTargeted therapyCateninBiologyPI3K/AKT/mTOR pathwayImmune systemCarcinogenesisProgenitor cellImmunologyCell biologyCancerSignal transductionGeneticsCancer-related gene regulationWnt/β-catenin signaling in development and cancerImmune Cell Function and Interaction